92 related articles for article (PubMed ID: 16638192)
41. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.
Maeda H; Hori S; Nishitoh H; Ichijo H; Ogawa O; Kakehi Y; Kakizuka A
Cancer Res; 2001 Jul; 61(14):5432-40. PubMed ID: 11454688
[TBL] [Abstract][Full Text] [Related]
42. [In vitro effect of all-trans retinoic acid on cell adhesion molecule expression and adhesion capacity of bone marrow stromal cells in patients received peripheral blood stem cell transplantation].
Chang C; Chen XH; Kong PY; Peng XG; Zeng DF; Yang WB; Liang X; Liu L; Liu H; Wang QY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug; 14(4):768-72. PubMed ID: 16928318
[TBL] [Abstract][Full Text] [Related]
43. Anti-apoptotic and apoptotic pathway analysis of arsenic trioxide‑induced apoptosis in human gastric cancer SGC-7901 cells.
Yu Y; Yang Y; Wang J
Oncol Rep; 2014 Sep; 32(3):973-8. PubMed ID: 24969414
[TBL] [Abstract][Full Text] [Related]
44. [Changes of gene expression profile of multiple myeloma cell line RPMI 8226 treated by arsenic trioxide].
Wang MC; Liu SX; Liu PB
Zhong Xi Yi Jie He Xue Bao; 2006 Mar; 4(2):160-5. PubMed ID: 16529693
[TBL] [Abstract][Full Text] [Related]
45. Arsenic trioxide downregulates the expression of annexin II in bone marrow cells from patients with acute myelogenous leukemia.
Zhang XH; Hu Y; Bao L; Jiang Q; Yang LH; Lu XJ; Hong M; Xia LH; Guo T; Shen GX; Zhu HH; Zhao T; Song SJ
Chin Med J (Engl); 2009 Sep; 122(17):1969-73. PubMed ID: 19781379
[TBL] [Abstract][Full Text] [Related]
46. Arsenic trioxide inhibits DNA methyltransferase and restores TMS1 gene expression in K562 cells.
Li H; Wang Y; Xu W; Dong L; Guo Y; Bi K; Zhu C
Acta Haematol; 2015; 133(1):18-25. PubMed ID: 24993472
[TBL] [Abstract][Full Text] [Related]
47. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
[TBL] [Abstract][Full Text] [Related]
48. Myeloma-derived macrophage inhibitory factor regulates bone marrow stromal cell-derived IL-6 via c-MYC.
Piddock RE; Marlein CR; Abdul-Aziz A; Shafat MS; Auger MJ; Bowles KM; Rushworth SA
J Hematol Oncol; 2018 May; 11(1):66. PubMed ID: 29769142
[TBL] [Abstract][Full Text] [Related]
49. Blockage of multidrug resistance-associated proteins potentiates the inhibitory effects of arsenic trioxide on CYP1A1 induction by polycyclic aromatic hydrocarbons.
Vernhet L; Allain N; Le Vée M; Morel F; Guillouzo A; Fardel O
J Pharmacol Exp Ther; 2003 Jan; 304(1):145-55. PubMed ID: 12490585
[TBL] [Abstract][Full Text] [Related]
50. [Study on the mechanism of arsenic trioxide inhibiting NB4 cells proliferation].
Yang GZ; Li W; Ma KW; Du ZH; Li L
Zhonghua Xue Ye Xue Za Zhi; 2009 Jun; 30(6):390-3. PubMed ID: 19951532
[TBL] [Abstract][Full Text] [Related]
51. [Effects of As2O3, dexamethasone and thalidomide on apoptosis and cytoplasmic [Ca2+] of myeloma cell line U266].
Lin RF; Lu H; Liu P; Wang YR; Shen WY; Wu YJ; Zhang JF; Fei XM; Ge Z; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1200-3. PubMed ID: 18088466
[TBL] [Abstract][Full Text] [Related]
52. Arsenic trioxide inhibits cell proliferation and human papillomavirus oncogene expression in cervical cancer cells.
Wang H; Gao P; Zheng J
Biochem Biophys Res Commun; 2014 Sep; 451(4):556-61. PubMed ID: 25117446
[TBL] [Abstract][Full Text] [Related]
53. [Primary research on arsenic trioxide inhibiting human breast cancer cells growth and its mechanisms].
Wei L; Wang XW; Zuo WS; Song XR
Zhonghua Yi Xue Za Zhi; 2005 May; 85(17):1209-13. PubMed ID: 16029599
[TBL] [Abstract][Full Text] [Related]
54. [Regulation of arsenic trioxide-inducing apoptosis].
Huang X
Zhonghua Xue Ye Xue Za Zhi; 1999 May; 20(5):258-60. PubMed ID: 11601217
[TBL] [Abstract][Full Text] [Related]
55. [The effect of As2O3 on induction of apoptosis and inhibition of telomerase activity in colon cancer LS-174T cells].
Wang XS; Wang GY; Xu HT; Wang K; Liu M; Fu SB; Geng JS; Zhang QF; Dong XS; Zhao JH
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):415-8. PubMed ID: 17974272
[TBL] [Abstract][Full Text] [Related]
56. Induction of apoptosis and inhibition of telomerase activity by arsenic trioxide (As2O3) in endometrial carcinoma cells.
Zhou C; Boggess JF; Bae-Jump V; Gehrig PA
Gynecol Oncol; 2007 Apr; 105(1):218-22. PubMed ID: 17275888
[TBL] [Abstract][Full Text] [Related]
57. Arsenic trioxide-induced apoptosis of Hep-2 cell line through modulating intracellular glutathione (GSH) level.
Cheng B; Yang X; An L; Gao B; Liu X
Auris Nasus Larynx; 2010 Feb; 37(1):89-94. PubMed ID: 19574005
[TBL] [Abstract][Full Text] [Related]
58. A comparison of cytokine production in 2-dimensional and 3-dimensional cultures of bone marrow stromal cells of multiple myeloma patients in response to RPMI8226 myeloma cells.
Zdzisińska B; Roliński J; Piersiak T; Kandefer-Szerszeń M
Folia Histochem Cytobiol; 2009; 47(1):69-74. PubMed ID: 19419941
[TBL] [Abstract][Full Text] [Related]
59. [The effect of arsenic trioxide (As2O3) combined with BSO on K562/ADM cell and its mechanisms].
Wang T; Ma LM; Zhang HP; Wang HW; Yang LH; Qiao ZH
Zhonghua Xue Ye Xue Za Zhi; 2007 Jul; 28(7):438-43. PubMed ID: 18072624
[TBL] [Abstract][Full Text] [Related]
60. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.
Tai YT; Li XF; Breitkreutz I; Song W; Neri P; Catley L; Podar K; Hideshima T; Chauhan D; Raje N; Schlossman R; Richardson P; Munshi NC; Anderson KC
Cancer Res; 2006 Jul; 66(13):6675-82. PubMed ID: 16818641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
